Publishing research using ab58227? Please let us know so that we can cite the reference in this datasheet.
ab58227 has been referenced in 3 publications.
Tan HL et al.Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.Mod Pathol N/A:N/A (2014).
Cathomas R et al.Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07).Clin Cancer Res 18:6049-6057 (2012).
Lamontagne J et al.Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis.J Virol 84:907-17 (2010).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"